JP Morgan 2025: Incyte expects period of ‘defining catalysts’ – Pharmaceutical Technology
The launches reportedly represent a potential $1bn in incremental revenues for Incyte by 2029. Credit: SOPA Images / Getty Images. Incyte CEO Hervé Hoppenot has